1 year return (CAGR)
13.09%
Arbutus Biopharma Corp Exchange (NASDAQ, USD)
ABUS
5.01
-0.06 (-1.18%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
34.70%
5 year return (CAGR)
2.72%
10 year return (CAGR)
2.95%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
992.51M
Price/Sales
5.46
Ent value
988.63M
Price/Book
3.84
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
6.48
PEG
-
Forward P/E
-
EPS growth
-26.95%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.04 |
| Daily high | 5.06 |
| Daily low | 4.98 |
| Daily Volume | 6.46M |
| All-time high | 30.94 |
| 1y analyst estimate | 5.53 |
| Beta | 0.60 |
| EPS (TTM) | 0.78 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ABUS | S&P500 | |
| Current price drop from All-time high | -83.81% | -2.08% |
| Highest price drop | -97.19% | -56.47% |
| Date of highest drop | 9 Oct 2019 | 9 Mar 2009 |
| Avg drop from high | -75.58% | -10.68% |
| Avg time to new high | 142 days | 12 days |
| Max time to new high | 3151 days | 1805 days |
News
